A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
A Large-Scale International Meta-Analysis of Paraoxonase Gene Polymorphisms in Sporadic ALS
Neurol 73:16-24,11, Wills,A.-M.,et al, 2009
Familial Amyotrophic Lateral Sclerosis
Muscle Nerve 25:135-159, Hand,C.K. &Rouleau,G.A., 2002
Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001
Amyotrophic Lateral Sclerosis and Occupational History
Arch Neurol 53:730-733, Strickland,D.,et al, 1996
Superoxide Dismutase and ALS
Lancet 344:1651-1652, Orrell,R.W.&deBelleroche,J.S., 1994
What Causes Motoneuron Disease?
Editorial, Lancet 336:1033-10351990., , 1990
Amyotrophic Lateral Sclerosis, Recent Advances in Pathogenesis & Therapeutic Trials
Arch Neurol 45:189-202, Mitsumoto,H.,et al, 1988
Amyotrophic Lateral Sclerosis Patient Antibodies Label CA2+Channel a1 Subunit
Ann Neurol 35:164-171, 1311994., Fumiharu,K.,et al, 1994
Cell Culture Evidence for Neuronal Degeneration in ALS to Glutamate AMPA/Kainate Receptors
Lancet 341:265-268, Couratier,P.,et al, 1993
Evidence for a Dopaminergic Deficit in Sporadic Amyoptrophic Lateral Sclerosis on Positron Emission Scanning
Lancet 324:1016-1018, Takahashi,H.,et al, 1993
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
NEJM 326:1464-1468, 14931992., Rothstein,J.D.,et al, 1992
Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Rising Mortality From Motoneuron Disease in the USA, 1962-84
Lancet 1:710-712, Lilienfeld,D.E.,et al, 1989